Delaware | 0-12933 | 94-2634797 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||
Item 2.02. | Results of Operations and Financial Condition | 3 | ||
Item 9.01. | Financial Statements and Exhibits | 3 | ||
SIGNATURES | 4 | |||
EXHIBIT INDEX | 5 | |||
EX-99.1 |
Item 2.02. | Results of Operations and Financial Condition |
Item 9.01. | Financial Statements and Exhibits |
Date: | October 19, 2016 | LAM RESEARCH CORPORATION | |
(Registrant) | |||
/s/ Douglas R. Bettinger | |||
Douglas R. Bettinger | |||
Executive Vice President, Chief Financial Officer | |||
(Principal Financial Officer and Principal Accounting Officer) |
• | Shipments of $1,708 million and revenue of $1,632 million. |
• | GAAP gross margin of 43.9%, GAAP operating margin of 19.4%, and GAAP diluted EPS of $1.47. |
• | Non-GAAP gross margin of 45.2%, non-GAAP operating margin of 22.4%, and non-GAAP diluted EPS of $1.81. |
U.S. GAAP | ||||||||||
September 2016 | June 2016 | Change Q/Q | ||||||||
Shipments | $ | 1,708,483 | $ | 1,587,417 | + 8% | |||||
Revenue | $ | 1,632,419 | $ | 1,546,261 | + 6% | |||||
Gross margin as percentage of revenue | 43.9 | % | 45.2 | % | -130 bps | |||||
Operating margin as percentage of revenue | 19.4 | % | 20.0 | % | - 60 bps | |||||
Diluted EPS | $ | 1.47 | $ | 1.46 | + 1% | |||||
Non-GAAP | ||||||||||
September 2016 | June 2016 | Change Q/Q | ||||||||
Shipments | $ | 1,708,483 | $ | 1,587,417 | + 8% | |||||
Revenue | $ | 1,632,419 | $ | 1,546,261 | + 6% | |||||
Gross margin as percentage of revenue | 45.2 | % | 46.6 | % | - 140 bps | |||||
Operating margin as percentage of revenue | 22.4 | % | 23.2 | % | - 80 bps | |||||
Diluted EPS | $ | 1.81 | $ | 1.80 | + 1% |
Region | Shipments | Revenue | |||
Taiwan | 26 | % | 26 | % | |
Korea | 28 | % | 23 | % | |
Japan | 11 | % | 15 | % | |
China | 11 | % | 14 | % | |
Southeast Asia | 11 | % | 12 | % | |
United States | 8 | % | 7 | % | |
Europe | 5 | % | 3 | % |
U.S. GAAP | Reconciling Items | Non-GAAP | ||||||||||
Shipments | $1.85 Billion | +/- | $75 Million | — | $1.85 Billion | +/- | $75 Million | |||||
Revenue | $1.84 Billion | +/- | $75 Million | — | $1.84 Billion | +/- | $75 Million | |||||
Gross margin | 44.9% | +/- | 1% | $ | 21 | Million | 46.0% | +/- | 1% | |||
Operating margin | 23.0% | +/- | 1% | $ | 37 | Million | 25.0% | +/- | 1% | |||
Net income per diluted share | $1.82 | +/- | $0.10 | $ | 60 | Million | $2.18 | +/- | $0.10 | |||
Diluted share count | 181 Million | 2 | Million | 179 Million |
• | Gross Margin - amortization related to intangible assets acquired in the Novellus transaction, $21 million. |
• | Operating margin - amortization related to intangible assets acquired in the Novellus transaction, $37 million. |
• | Earnings per share - amortization related to intangible assets acquired in the Novellus transaction, $37 million; amortization of note discounts, $6 million; special mandatory redemption fees, accelerated amortization of loan issuance costs and debt discounts, and interest expense, net associated with the early redemption of the KLA-Tencor acquisition funding, $37 million; and associated tax benefit for non-GAAP items ($20) million; totaling $60 million. |
• | Diluted share count - impact of a note hedge issued contemporaneously with the convertible notes due 2018, 2 million shares. |
Three Months Ended | |||||||||||
September 25, 2016 | June 26, 2016 | September 27, 2015 | |||||||||
Revenue | $ | 1,632,419 | $ | 1,546,261 | $ | 1,600,043 | |||||
Cost of goods sold | 916,222 | 847,477 | 877,680 | ||||||||
Gross margin | 716,197 | 698,784 | 722,363 | ||||||||
Gross margin as a percent of revenue | 43.9 | % | 45.2 | % | 45.1 | % | |||||
Research and development | 235,240 | 237,255 | 234,209 | ||||||||
Selling, general and administrative | 165,010 | 152,288 | 152,726 | ||||||||
Total operating expenses | 400,250 | 389,543 | 386,935 | ||||||||
Operating income | 315,947 | 309,241 | 335,428 | ||||||||
Operating income as a percent of revenue | 19.4 | % | 20.0 | % | 21.0 | % | |||||
Other expense, net | (23,154 | ) | (27,249 | ) | (27,121 | ) | |||||
Income before income taxes | 292,793 | 281,992 | 308,307 | ||||||||
Income tax expense | (28,958 | ) | (23,053 | ) | (19,628 | ) | |||||
Net income | $ | 263,835 | $ | 258,939 | $ | 288,679 | |||||
Net income per share: | |||||||||||
Basic | $ | 1.64 | $ | 1.62 | $ | 1.82 | |||||
Diluted | $ | 1.47 | $ | 1.46 | $ | 1.66 | |||||
Number of shares used in per share calculations: | |||||||||||
Basic | 160,607 | 159,862 | 158,352 | ||||||||
Diluted | 180,017 | 177,649 | 174,374 | ||||||||
Cash dividend declared per common share | $ | 0.30 | $ | 0.30 | $ | 0.30 |
September 25, 2016 | June 26, 2016 | September 27, 2015 | ||||||||||
(unaudited) | (1) | (unaudited) | ||||||||||
ASSETS | ||||||||||||
Cash and cash equivalents | $ | 5,861,701 | $ | 5,039,322 | $ | 1,744,325 | ||||||
Investments | 1,352,775 | 1,788,612 | 2,587,474 | |||||||||
Accounts receivable, net | 1,290,317 | 1,262,145 | 1,088,942 | |||||||||
Inventories | 931,581 | 971,911 | 916,683 | |||||||||
Other current assets | 162,628 | 151,160 | (3) | 177,668 | (3) | |||||||
Total current assets | 9,599,002 | 9,213,150 | 6,515,092 | |||||||||
Property and equipment, net | 649,587 | 639,608 | 636,769 | |||||||||
Restricted cash and investments | 255,640 | 250,421 | 183,455 | |||||||||
Goodwill and intangible assets | 1,912,431 | 1,951,197 | 2,076,164 | |||||||||
Other assets | 219,702 | 209,939 | (3) | 177,859 | (3) | |||||||
Total assets | $ | 12,636,362 | $ | 12,264,315 | $ | 9,589,339 | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||
Current portion of convertible notes and capital leases | $ | 952,999 | $ | 947,733 | (3) | $ | 968,503 | (3) | ||||
Other current liabilities | 1,533,253 | 1,470,308 | 1,312,549 | |||||||||
Total current liabilities | 2,486,252 | 2,418,041 | 2,281,052 | |||||||||
Long-term debt and capital leases | 3,378,179 | 3,378,129 | (3) | 1,396,412 | (3) | |||||||
Income taxes payable | 241,671 | 231,514 | 247,448 | |||||||||
Other long-term liabilities | 142,910 | 134,562 | 127,607 | |||||||||
Total liabilities | 6,249,012 | 6,162,246 | 4,052,519 | |||||||||
Temporary equity, convertible notes | 202,467 | 207,552 | 178,665 | |||||||||
Stockholders’ equity (2) | 6,184,883 | 5,894,517 | 5,358,155 | |||||||||
Total liabilities and stockholders’ equity | $ | 12,636,362 | $ | 12,264,315 | $ | 9,589,339 |
(1) | Derived from audited financial statements |
(2) | Common shares issued and outstanding were 161,706 as of September 25, 2016, 160,201 as of June 26, 2016, and 158,101 as of September 27, 2015 |
(3) | Adjusted for effects of retrospective implementation of ASU 2015-3, regarding the simplification of the presentation of bond issuance costs, which requires that bond issuance costs related to a recognized liability be presented on the balance sheet as a direct reduction from the carrying amount of that debt liability, consistent with debt discounts. |
Three Months Ended | |||||||||||
September 25, 2016 | June 26, 2016 | September 27, 2015 | |||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
Net income | $ | 263,835 | $ | 258,939 | $ | 288,679 | |||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation and amortization | 74,562 | 74,976 | 70,590 | ||||||||
Deferred income taxes | 7,633 | (46,708 | ) | (5,563 | ) | ||||||
Equity-based compensation expense | 38,595 | 39,288 | 35,774 | ||||||||
Income tax benefit on equity-based compensation plans | — | (8,048 | ) | 3,545 | |||||||
Excess tax benefit on equity-based compensation plans | — | 9,035 | (3,572 | ) | |||||||
Amortization of note discounts and issuance costs | 6,830 | 14,584 | 9,831 | ||||||||
Gain on sale of assets | — | (15,223 | ) | — | |||||||
Other, net | 16,807 | 17,929 | 10,011 | ||||||||
Changes in operating assets and liabilities | 64,962 | 79,052 | 39,702 | ||||||||
Net cash provided by operating activities | 473,224 | 423,824 | 448,997 | ||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||
Capital expenditures and intangible assets | (41,979 | ) | (51,726 | ) | (49,454 | ) | |||||
Net sale (purchase) of available-for-sale securities | 431,750 | 605,891 | (28,203 | ) | |||||||
Proceeds from sale of assets | — | 79,730 | — | ||||||||
Transfer of restricted cash and investments | (5,219 | ) | (112,381 | ) | — | ||||||
Other, net | (7,800 | ) | — | (1,500 | ) | ||||||
Net cash provided by (used for) investing activities | 376,752 | 521,514 | (79,157 | ) | |||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs | (371 | ) | (450,624 | ) | (96 | ) | |||||
Proceeds from issuance of long-term debt, net of issuance costs | — | 2,374,220 | — | ||||||||
Excess tax benefit on equity-based compensation plans | — | (9,035 | ) | 3,572 | |||||||
Treasury stock purchases | (1,854 | ) | (27,114 | ) | (98,385 | ) | |||||
Dividends paid | (48,052 | ) | (47,308 | ) | (47,659 | ) | |||||
Reissuance of treasury stock related to employee stock purchase plan | 19,320 | 20,360 | 19,245 | ||||||||
Proceeds from issuance of common stock | 1,459 | 1,547 | 377 | ||||||||
Other, net | (10 | ) | (159 | ) | (300 | ) | |||||
Net cash (used for) provided by financing activities | (29,508 | ) | 1,861,887 | (123,246 | ) | ||||||
Effect of exchange rate changes on cash and cash equivalents | 1,911 | 76 | (3,808 | ) | |||||||
Net increase in cash and cash equivalents | 822,379 | 2,807,301 | 242,786 | ||||||||
Cash and cash equivalents at beginning of period | 5,039,322 | 2,232,021 | 1,501,539 | ||||||||
Cash and cash equivalents at end of period | $ | 5,861,701 | $ | 5,039,322 | $ | 1,744,325 |
Three Months Ended | |||||||
September 25, 2016 | June 26, 2016 | ||||||
Revenue | $ | 1,632,419 | $ | 1,546,261 | |||
Gross margin | $ | 737,447 | $ | 720,162 | |||
Gross margin as percentage of revenue | 45.2 | % | 46.6 | % | |||
Operating expenses | $ | 371,634 | $ | 361,490 | |||
Operating income | $ | 365,813 | $ | 358,672 | |||
Operating margin as a percentage of revenue | 22.4 | % | 23.2 | % | |||
Net income | $ | 322,074 | $ | 314,806 | |||
Net income per diluted share | $ | 1.81 | $ | 1.80 | |||
Shares used in per share calculation - diluted | 177,628 | 175,052 |
Three Months Ended | |||||||
September 25, 2016 | June 26, 2016 | ||||||
U.S. GAAP net income | $ | 263,835 | $ | 258,939 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold | 21,250 | 21,250 | |||||
Novellus acquisition-related inventory fair value impact - cost of goods sold | — | 128 | |||||
Costs associated with campus consolidation - research and development | 2,561 | 7,763 | |||||
Restructuring charges - research and development | — | 43 | |||||
Amortization related to intangible assets acquired in Novellus transaction -selling, general and administrative | 16,083 | 16,083 | |||||
KLA-Tencor acquisition-related costs - selling, general and administrative | 9,972 | 19,270 | |||||
Restructuring charges - selling, general and administrative | — | 117 | |||||
Gain on sale of real property, net of associated exit costs - selling, general and administrative | — | (15,223 | ) | ||||
KLA-Tencor acquisition funding interest expense, net - other expense, net | 17,709 | 3,821 | |||||
Amortization of note discounts - other expense, net | 5,913 | 7,492 | |||||
Amortization of bridge loan issuance costs and other related fees - other expense, net | — | 6,938 | |||||
Net income tax benefit on non-GAAP items | (15,249 | ) | (8,413 | ) | |||
Income tax benefit on resolution of certain tax matters | — | (2,515 | ) | ||||
Change to income tax benefit from court ruling | — | (887 | ) | ||||
Non-GAAP net income | $ | 322,074 | $ | 314,806 | |||
Non-GAAP net income per diluted share | $ | 1.81 | $ | 1.80 | |||
U.S. GAAP number of shares used for per diluted share calculation | 180,017 | 177,649 | |||||
Effect of convertible note hedge | (2,389 | ) | (2,597 | ) | |||
Non-GAAP number of shares used for per diluted share calculation | 177,628 | 175,052 |
Three Months Ended | |||||||
September 25, 2016 | June 26, 2016 | ||||||
U.S. GAAP gross margin | $ | 716,197 | $ | 698,784 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired in Novellus transaction | 21,250 | 21,250 | |||||
Novellus acquisition-related inventory fair value impact | — | 128 | |||||
Non-GAAP gross margin | $ | 737,447 | $ | 720,162 | |||
U.S. GAAP gross margin as a percentage of revenue | 43.9 | % | 45.2 | % | |||
Non-GAAP gross margin as a percentage of revenue | 45.2 | % | 46.6 | % | |||
U.S. GAAP operating expenses | $ | 400,250 | $ | 389,543 | |||
Pre-tax non-GAAP items: | |||||||
Amortization related to intangible assets acquired in Novellus transaction | (16,083 | ) | (16,083 | ) | |||
KLA-Tencor acquisition-related costs | (9,972 | ) | (19,270 | ) | |||
Costs associated with campus consolidation | (2,561 | ) | (7,763 | ) | |||
Restructuring charges | — | (160 | ) | ||||
Gain on sale of real property, net of associated exit costs | — | 15,223 | |||||
Non-GAAP operating expenses | $ | 371,634 | $ | 361,490 | |||
Non-GAAP operating income | $ | 365,813 | $ | 358,672 | |||
GAAP operating margin as percent of revenue | 19.4 | % | 20.0 | % | |||
Non-GAAP operating margin as a percent of revenue | 22.4 | % | 23.2 | % |